Kyntra Bio (KYNB)

• Market cap: $28M
• 1 day: -0.57%
• 5 days: -16.51%
• 1 month: -17.79%
• 3 months: -21.25%
• 6 months: -33.87%
• Year to date: -24.34%
• 1 year: -31.25%
• 5 years: -99.45%
• 10 years: -98.4%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 225